TOX3, TOX high mobility group box family member 3, 27324
N. diseases: 49; N. variants: 11
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.770 | 0.875 | 8 | 2007 | 2016 | |||||||
|
0.925 | 0.080 | 16 | 52500255 | intron variant | T/C | snv | 0.61 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.770 | 0.875 | 8 | 2007 | 2019 | |||||||
|
1.000 | 0.080 | 16 | 52532542 | intron variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.080 | 16 | 52541995 | intron variant | A/G | snv | 0.32 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.857 | 7 | 2009 | 2016 | |||||||
|
0.925 | 0.080 | 16 | 52500255 | intron variant | T/C | snv | 0.61 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.070 | 0.857 | 7 | 2010 | 2019 | |||||||
|
0.925 | 0.080 | 16 | 52543923 | intron variant | T/A | snv | 0.51 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 16 | 52543923 | intron variant | T/A | snv | 0.51 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.807 | 0.120 | 16 | 52514125 | intron variant | A/G | snv | 0.48 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 16 | 52530039 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.080 | 16 | 52530039 | intron variant | G/C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.080 | 16 | 52454795 | intron variant | C/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 16 | 52454795 | intron variant | C/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
16 | 52463957 | missense variant | G/A | snv | 6.6E-04 | 8.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 16 | 52549231 | upstream gene variant | C/T | snv | 0.20 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 16 | 52505685 | intron variant | A/G | snv | 0.41 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 16 | 52505685 | intron variant | A/G | snv | 0.41 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 16 | 52505685 | intron variant | A/G | snv | 0.41 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 16 | 52494395 | intron variant | T/C;G | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |